akhatri

The Department of Health and Social Care (DHSC) has published details of its ongoing work and plans to improve the management of medicines supply issues. This includes a commitment to consulting on the introduction of pharmacist flexibilities to supply alternatives when a medicine is in short supply. The new policy paper, Managing a robust and [...]

The post DHSC outlines work to improve medicines supply appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Topiramate Zydus Pharmaceuticals UK 20mg/ml Oral Solution, Zydus Pharmaceuticals UK Ltd Drug alert number: EL(25)A/39 Date issued: 07 August 2025 Zydus Pharmaceuticals UK LTD has informed the MHRA that there is an error on the artwork for the outer carton and Patient Information Leaflet (PIL) of Topiramate Zydus Pharmaceuticals UK [...]

The post Class 4 Medicines Defect Notification: Topiramate Zydus Pharmaceuticals UK 20mg/ml Oral Solution, Zydus Pharmaceuticals UK Ltd appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 August 2025. Generic drug name (dm+d descriptor) Brand and/or Manufacturer Pack size Special container Hydrocortisone 500microgram granules in capsules for opening Alkindi® 0.5 mg granules in capsules [...]

The post 10 products re-classified as special containers from August 2025 appeared first on Community Pharmacy England.

National Patient Safety Alert: Shortage of Antimicrobial Agents Used in Tuberculosis (TB) Treatment National Patient Safety Alert Reference Number: NatPSA/2025/004/MVA Date issued: 29 July 2025 Explanation of identified issue: The following antimicrobial medicines used to treat tuberculosis (TB) will be intermittently available until at least the end of 2025: Rifampicin 150mg and 300mg capsules Rifampicin [...]

The post National Patient Safety Alert: Shortage of Antimicrobial Agents Used in Tuberculosis (TB) Treatment appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Flutiform 250 micrograms / 10 micrograms per actuation pressurised inhalation, suspension (CD Pharma Ltd) Drug alert number: EL(25)A/35 Date issued: 24 July 2025 CD Pharma Ltd have notified the MHRA of an error on the outer carton of the product for the batches listed in this notification. While the total [...]

The post MHRA Class 2 Medicines Recall: Flutiform 250 micrograms / 10 micrograms per actuation pressurised inhalation, suspension (CD Pharma Ltd) appeared first on Community Pharmacy England.